During the past decade, Roskamp Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 12 clinical trials were completed, i.e. on average, 70.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Roskamp Institute" #1 sponsor was "Roskamp Institute Inc." with 5 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "TauRx Therapeutics Ltd" with 3 trials sponsored and "AstraZeneca" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Roskamp Institute" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "United States Department of Defense" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Roskamp Institute" are "Alzheimer's Disease" (15 trials), "Alzheimer Disease" (10 trials), "Gulf War Illness" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials) and "Mild Cognitive Impairment" (2 trials). Many other conditions were trialed in "Roskamp Institute" in a lesser frequency.

Most popular intervention types in "Roskamp Institute" are "Drug" (32 trials) and "Dietary Supplement" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Placebo Control" (3 trials), "placebo" (3 trials) and "AVP-786" (2 trials). Other intervention names were less common.

The vast majority of trials in "Roskamp Institute" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Roskamp Institute". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Roskamp Institute, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Roskamp Institute, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".